Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection

Blood

Volumn 87, Issue 4, 1996, Pages 1446-1457

  Imai, Shosuke ^a   Sugiura, Makoto ^b   Oikawa, Ou ^b   Koizumi, Shigeki ^b   Hirao, Motoyasu ^b   Kimura, Hiroshi ^b   Hayashibara, Hiroshi ^b   Terai, Norio ^b   Tsutsumi, Hiroyuki ^b   Oda, Takanori ^b   Chiba, Shunzo ^b   Osato, Toyoro ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MEMBRANE PROTEIN; PHORBOL ESTER DERIVATIVE; T LYMPHOCYTE RECEPTOR; VIRUS ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; PRIMER DNA; VIRUS DNA;

ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSURVEILLANCE; INFANT; LYMPH NODE BIOPSY; LYMPHOCYTE DIFFERENTIATION; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE; T LYMPHOCYTE SUBPOPULATION; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTION; VIRUS LATENCY; CELL LINE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HERPES VIRUS INFECTION; MICROBIOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRESCHOOL CHILD; T LYMPHOCYTE; VIRUS CELL TRANSFORMATION;

BASE SEQUENCE; CELL LINE; CELL TRANSFORMATION, VIRAL; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENE REARRANGEMENT, T-LYMPHOCYTE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; MALE; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RNA, MESSENGER; T-LYMPHOCYTES; TUMOR VIRUS INFECTIONS;

EID: 0029664685     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1446.bloodjournal8741446     Document Type: Article

References (62)

1. Miller G: Epstein-Barr virus. Biology, pathogenesis, and medical aspects, in Fields BN, Knipe DM (eds): Fields Virology (ed 2). New York, NY, Raven, 1990, p 1921
2. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T: Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335:128, 1990
3. Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CJ, Cheng AL, Kadin ME, Chen JY: Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysis. Blood 77:799, 1991
4. Korbjuhn P, Anagnostopoulos I, Hummel M, Tiemann M, Dallenbach F, Parwaresch MR, Stein H: Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in HIV negative European pleomorphic T cell lymphomas. Blood 82:217, 1993
5. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS: Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337:320, 1991
6. Weiss LM, Chen YY, Liu XF, Shibata D: Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 139:1259, 1991
7. Dimery IW, Lee JS, Blick M, Pearson G, Spitzer G, Hong WK: Association of the Epstein-Barr virus with lymphoepithelioma of the thymus. Cancer 61:2475, 1988
8. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM: Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 139:469, 1991
9. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T: Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91:9131, 1994
10. McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Parmley RT, DiCarlo FJ, Chadwick EG, Murphy SB: Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 332:12, 1995
11. Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS: The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 332:19, 1995
12. Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, Purtilo DT: Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev 4:129, 1991
13. Straus SE: The chronic mononucleosis syndrome. J Infect Dis 157:405, 1988
14. Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T, Koizumi S, Osato T, Kobayashi I, Hamada I, Hirai K: Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333:455, 1988
15. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, Sands J, Gottman D, Katz BZ, Sklar J: T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318:733, 1988
16. Ishihara S, Tawa A, Yumura-Yagi K, Murata M, Hara J, Yabuuchi H, Hirai K, Kawa-Ha K: Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection. Jpn J Cancer Res 80:99, 1989
17. Bonagura VR, Katz BZ, Edwards BL, Valacer DJ, Nisen P, Gloster E, Mir R, Lanzkowsky P: Severe chronic EBV infection associated with specific EBV immunodeficiency and an EBNA+ T-cell lymphoma containing linear, EBV DNA. Clin Immunol Immunopathol 57:32, 1990
18. Tanaka Y, Sasaki Y, Kurozumi H, Hyodo Y, Nishi T, Nakatani Y, Imai S, Osato T: Angiocentric immunoproliferative lesion associated with chronic active Epstein-Barr virus infection in an 11-year-old boy. Clonotypic proliferation of Epstein-Barr virus-bearing CD4+ T lymphocytes. Am J Surg Pathol 18:623, 1994
19. Pallesen G, Hamilton-Dutoit SJ, Zhou X: The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: Two new developments in the EBV field. Adv Cancer Res 62:179, 1993
20. Hedrick JA, Watry D, Speiser C, O'Donnell P, Lambris JD, Tsoukas CD: Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2. Eur J Immunol 22:1123, 1992
21. Koizumi S, Zhang XK, Imai S, Sugiura M, Usui N, Osato T: Infection of the HTLV-I-harboring T-lymphoblastoid line MT-2 by Epstein-Barr virus. Virology 188:859, 1992
22. Stevenson M, Volsky B, Hedenskog M, Volsky DJ: Immortalization of human T lymphocytes after transfection of Epstein-Barr virus DNA. Science 233:980, 1986
23. Watry D, Hedrick JA, Siervo S, Rhodes G, Lamberti JJ, Lambris JD, Tsoukas CD: Infection of human thymocytes by Epstein-Barr virus. J Exp Med 173:971, 1991
24. Osato T, Mizuno F, Imai S, Aya T, Koizumi S, Kinoshita T, Tokuda H, Ito Y, Hirai N, Hirota M, Ohigashi H, Koshimizu K, Kofi-Tsekpo WM, Were JBO, Mugambi M: African Burkitt's lymphoma and an Epstein-Barr virus-enhancing plant Euphorbia tirucalli. Lancet 1:1257, 1987
25. Miller G, Lipman M: Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 70:190, 1973
26. Miyoshi I, Hiraki S, Tsubota T, Kubonishi I, Matsuda Y, Nakayama T, Kishimoto H, Kimura I: Human B cell, T cell and null cell leukaemic cell lines derived from acute lymphoblastic leukaemias. Nature 267:843, 1977
27. Koizumi S, Sugiura M, Zhang XK, Yamashiro K, Iwanaga M, Imai S, Osato T: Simultaneous expression of T-cell and myeloid cell phenotypes in eight newly established HTLV-I-positive T-cell lines. Jpn J Cancer Res 83:929, 1992
28. Imai S, Usui N, Sugiura M, Osato T, Sato T, Tsutsumi H, Tachi N, Nakata S, Yamanaka T, Chiba S, Shimada M: Epstein-Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infections. J Med Virol 40:278, 1993
29. Berneman ZN, Ablashi DV, Li G, Eger-Fletcher M, Reitz MS Jr, Hung CL, Brus I, Komaroff AL, Gallo RC: Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and cytomegalovirus. Proc Natl Acad Sci USA 89:10552, 1992
30. Matsumoto C, Mitsunaga S, Oguchi T, Mitomi Y, Shimada T, Ichikawa A, Watanabe J, Nishioka K: Detection of human T-cell leukemia virus type I (HTLV-I) provirus in an infected cell line and in peripheral mononuclear cells of blood donors by the nested double polymerase chain reaction method: Comparison with HTLV-I antibody tests. J Virol 64:5290, 1990
31. Ou CY, Kwok S, Mitchell SW, Mack DH, Sninsky JJ, Krebs JW, Feorino P, Warfield D, Schochetman G: DNA amplification for direct detection of HIV-I in DNA of peripheral blood mononuclear cells. Science 238:295, 1988
32. Yoshikai Y, Anatoniou D, Clark SP, Yanagi Y, Sangster R, Van den Elsen P, Terhorst C, Mak TW: Sequence and expression of transcripts of the human T-cell receptor β-chain genes. Nature 312:521, 1984
33. Lefranc MP, Forster A, Rabbitts TH: Rearrangement of two distinct T-cell γ-chain variable-region genes in human DNA. Nature 319:420, 1986
34. Tkachuk DC, Griesser H, Takihara Y, Champagne E, Minden M, Feller AC, Lennert K, Mak TW: Rearrangement of T-cell δ locus in lymphoproliferative disorders. Blood 72:353, 1988
35. Cleary ML, Chao J, Warnke R, Sklar J: Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci USA 81:593, 1984
36. Raab-Traub N, Rajadurai P, Flynn K, Lanier AP: Epstein-Barr virus infection in carcinoma of the salivary gland. J Virol 65:7032, 1991
37. Matsuo T, Heller M, Petti L, O'Shiro E, Kieff E: Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA. Science 226:1322, 1984
38. Hurley EA, Agger S, McNeil JA, Lawrence JB, Calender A, Lenoir G, Thorley-Lawson DA: When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates. J Virol 65:1245, 1991
39. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB: Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051, 1988
40. Finke J, Rowe M, Kallin B, Ernberg I, Rosén A, Dillner J, Klein G: Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J Virol 61:3870, 1987
41. Young LS, Lau R, Rowe M. Niedobitek G, Packham G, Shanahan F, Rowe DT, Greenspan D, Greenspan JS, Rickinson AB, Farrell PJ. Differentiation-associated expression of the Epstein-Barr virus BZLFI transactivator protein in oral hairy leukoplakia. J Virol 65:2868, 1991
42. Pearsou GR, Vroman B, Chase B, Sculley T, Hummel M, Kieff E: Identification of polypeptide components of the Epstein-Barr virus early antigen complex using monoclonal antibodies. J Virol 47:193, 1983
43. Fujiwara S: Studies on the synthesis of Epstein-Barr virus-related antigens induced by super-infection. [in Japanese with English abstract] Hokkaido J Med Sci 59:586, 1984
44. zur Hausen H, O'Neill FJ, Freese UK, Hecker E: Persisting oncogenic herpesvirus induced by the tumor promoter TPA. Nature 272:373, 1978
45. Brooks L, Yao QY, Rickinson AB, Young LS: Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression of EBNA1, LMP1. and LMP2 transcripts. J Virol 66:2689, 1992
46. Busson P, McCoy R, Sadler R, Gilligan K, Tursz T, Raab-Traub N: Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol 66:3257, 1992
47. Roncella S, Ramarli D, Cooper MK, Form M, Caretto P, Rowe M, Francia Di Celle P, Sessarego M, Foà R, Form G, Burrows P, Pistoia V, Ferrarini M: Establishment of an EBV-positive lymphoblastoid cell line that grows as a lymphoma in nude mice and expresses membrane CD2 molecules. Int J Cancer 45:299, 1990
48. Al Saati T, Delécluze HJ, Chittal S, Brousset P, Magaud JP, Dastugue N, Cohen-Knafo E, Laurent G, Rubin B, Delsol G: A novel human lymphoma cell line (Deglis) with dual B/T phenotype and gene rearrangements and containing Epstein-Barr virus genomes. Blood 80:209, 1992
49. Asada H, Okada N, Hashimoto K, Yamanishi K, Sairenji T, Hirota S, Nomura S, Kitamura Y, Yoshikawa K: Establishment and characterization of the T-cell line, EBT-8 latently infected with Epstein-Barr virus from large granular lymphocyte leukemia. Leukemia 8:1415, 1994
50. Fingeroth JD, Clabby ML, Strommger JD: Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). J Virol 62:1442, 1988
51. Tsoukas CD, Lambris JD: Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur J Immunol 18:1299, 1988
52. Sauvageau G, Stocco R, Kasparian S, Menézes J: Epstein-Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes. J Gen Virol 71:379, 1990
53. Fischer E, Delibrias C, Kazatchkine MD: Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 146:865, 1991
54. Freeman CB, Magrath IT, Benjamin D, Makuch R, Douglass EC, Santaella ML: Classification of cell lines derived from undifferentiated lymphomas according to their expression of complement and Epstein-Barr virus receptors: Implications for the relationship between African and American Burkitt's lymphoma. Clin Immunol Immunopathol 25, 103, 1982
55. Rowe M, Gregory C: Epstein-Barr virus and Burkitt's lymphoma. Adv Viral Oncol 8:237, 1989
56. Chen CL, Sadler RH, Walling DM, Su IJ, Hsieh HC, Raab-Traub N: Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol 67:6303, 1993
57. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB: Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies. J Exp Med 176:157, 1992
58. Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ: Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: Implications for vaccine development. J Exp Med 176: 169, 1992
59. Joncas J, Monczak Y, Ghibu F, Alfieri C, Bonin A, Ahronheim G, Rivard G: Brief report: Killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection. J Med Virol 28:110, 1989
60. Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur DC, Balfour HH, McClain K, Simmons RL, Najarian JS: Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 198:356, 1983
61. Kawa-Ha K, Franco E, Doi S, Yumura K, Ishihara S, Tawa A, Yabuuchi H: Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2. Lancet 1:154, 1987
62. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Séguin C, Tuffnell PL, Barrell BG: DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207, 1984